CG Oncology Rg
CGON
USD
STOCK MARKET:
NMS
Open
 
...
Large gap with delayed quotes
Last quote
04/27/2026 - 16:32:57
Bid
04/27/2026 - 16:32:59
Bid
Volume 		Ask
04/27/2026 - 16:32:59
Ask
Volume
68.93
+0.25 ( +0.36% )
68.92
100
69.01
100
More information
Analysis by TheScreener
24.04.2026
Evaluation Slightly negative  
Interest Very weak  
Sensibility Middle  
Analysis date: 24.04.2026
Global Evaluation
  Slightly negative
The stock is classified in the slightly negative zone since 24.04.2026.
Interest
  Very weak
One star since 24.04.2026.
Earnings Rev Trend
  Negative
 
Compared to seven weeks ago, the analysts have lowered their earnings per share estimates. This negative trend began 21.04.2026 at a price of 71.84.
Evaluation
  Strongly overvalued
 
Based on its growth potential and our own criteria, we believe the share price is currently overvalued.
MT Tech Trend
  Positive
 
The dividend-adjusted forty day technical trend is positive since 21.04.2026.
4wk Rel Perf
  -1.70%
 
The four-week dividend-adjusted underperformance versus SP500 is 1.70%.
Sensibility
  Middle
The stock has been on the moderate-sensitivity level since 21.04.2026.
Bear Market Factor
  Low
On average, the stock has a tendency to minimize the drops in the index by -0.93%.
Bad News Factor
  Low
When the stock's pressure is specific, the market sanction on average is 2.90%.
Mkt Cap in $bn
  5.80
With a market capitalization between $2 & $8bn, CG ONCOLOGY is considered a mid-cap stock.
G/PE Ratio
  0.04
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) below 0.6 indicates that investors must pay a substantial premium for the estimated growth potential: >50% premium.
LT P/E
  1316.37
The estimated PE is for the year 2028.
LT Growth
  51.74%
The annualized growth estimate is for the current year to 2028.
Avg. Nb analysts
  13
Over the last seven weeks, an average of 13 analysts provided earnings per share estimates.
Dividend Yield
  0.00%
The company is not paying a dividend.
Beta
  57
For 1% of index variation, the stock varies on average by 0.57%.
Correlation
  0.11
Stock movements are totally independent of index variations.
Value at Risk
  16.48
The value at risk is estimated at USD 16.48. The risk is therefore 24.00%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
  21.04.2026